Search
Now showing items 31-40 of 68
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report
(2021-05)
Background: Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus -19 pandemic, ...
New Psychoactive Substances (NPS) and Serotonin Syndrome onset: a Systematic Review
(2021-05-01)
The use of several new psychoactive substances (NPS) has become very popular and is posing global health risks. Chemically and pharmacologically diverse molecules are constantly emerging and are presenting with a wide range ...
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
(2021-04-23)
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of ...
The e-psychonaut drugs’ psychopharmacology
(2021-04-01)
The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g. synthetic cannabimimetics, synthetic opioids, novel stimulants, novel psychedelics, PCP/ketamine-like ...
Treatment of kratom use disorder with a classical tricyclic antidepressant: A case report and review
(2021-03-31)
Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe ...
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
(2021-03-10)
Abstract: Introduction: Cognitive enhancers (CEs), also known as ‘smart drugs,’ ‘study aids’ or ‘nootropics’ are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university ...
Opioid painkillers' dependence in a sample of elderly medical inpatients
(2021-02-16)
BACKGROUND: Over the past few years there has been a growing concern towards prescription opioid misuse/dependence in the elderly. Thus, our study aimed at investigating the prevalence of previous and current prescribing ...
Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach
(2021-02-09)
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, ...
The benzydamine experience: A systematic review of Benzydamine abuse
(2021-01-13)
Background: Both prescription and over-the-counter (OTC) drugs recently emerged among novel psychoactive substances (NPS) being reported as ingested for recreational purposes. Among them, benzydamine (BZY), normally ...